Daily as of 3 Nov 16:00 ET
- Price
- below both $10.41 vs 50 $11.94 / 200 $17.25
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 10 Sep 2026 · projected 30 bars out
GLUE | Monte Rosa TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$10.41
-$0.22 (-2.07%)
Monte Rosa Therapeutics (GLUE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $10.76 vs 50 $17.22 / 200 $8.80
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 15 Dec 2025 · projected 17 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $10.41 vs 50 $10.58 / 200 $15.92
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 18 Aug 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 10 Sep 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 18 Aug 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 24 Jun 2026 | 🟨Golden | 4-hour | 2 bars out | Not tested |
| 5 Jun 2026 | 💀Death | 4-hour | 3 bars out | Not tested |
| 3 Jun 2026 | 🟨Golden | 4-hour | 1 bar out | Not tested |
About GLUE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall